Our People

Mark Robbins, PhD JD Chief Operating Officer

Mark is a bio-pharmaceutical drug development professional with over 30 years of broad-based industry experience. Most recently, he has been working with a number of biotech companies through Kodiak Strategic Consultants, his Clinical/Regulatory management consulting firm. At Kodiak he served as CEO of Tychon Biosciense, a targeted drug delivery biotech venture, and currently serves as President of Tansna Therapeutics, a CNS drug discovery and development venture. Mark was Executive Vice President of Legal, Scientific and Technical Operations at Upsher-Smith. He started his career at Mallinckrodt as a research pharmacologist/ toxicologist, working his way to Director of Medical and Regulatory Affairs.

Mark is past Chair of the Food and Drug Law section of the MN State Bar Association and taught Food and Drug law at various law schools. He has overseen development and successfully implemented regulatory/clinical strategies leading to numerous successful NDA/BLA approvals and has expertise in regulatory/clinical strategy. Mark received a PhD in Pharmacology and a law degree. He is a Diplomate of the American Board of Toxicology and received a Regulatory Affairs Certification. Mark serves on the Board of Wishes & More, a wish-granting organization for children with terminal and life-threatening illnesses. Mark enjoys spending his free time on his bicycle and is an avid reader.

Back to All